Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News TerSera Therapeutics real-world ziconotide data at ASPN 2025 shows rising guideline-based intrathecal pain therapy adoption TerSera Therapeutics highlights real-world ziconotide prescribing trends at ASPN 2025, signaling growing guideline-aligned adoption in chronic pain management. byPallavi MadhirajuJuly 19, 2025